Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
Ann Neurol
    September 2025
  1. KIM J, Shulman JM
    Pleiotropy and the Increasing Complexity of Parkinson's Disease Genetics.
    Ann Neurol. 2025 Sep 13. doi: 10.1002/ana.78036.
    >> Share

    August 2025
  2. DE NEELING MGJ, Keulen BJ, Stam MJ, Hubers D, et al
    Beta Power Response After Levodopa Intake in Parkinson's Disease Patients With Chronic Sensing-Enabled Deep Brain Stimulation.
    Ann Neurol. 2025 Aug 29. doi: 10.1002/ana.78025.
    >> Share

  3. MULLER L, Ozduzenciler P, Schedlich-Teufer C, Seger A, et al
    Reply to "Urinary alpha-Synuclein for Parkinson's Detection: Key Limitations and Future Directions".
    Ann Neurol. 2025 Aug 11. doi: 10.1002/ana.70023.
    >> Share

  4. MA J, Deng P, Liu S
    Urinary alpha-Synuclein for Parkinson's Detection: Key Limitations and Future Directions.
    Ann Neurol. 2025 Aug 11. doi: 10.1002/ana.70018.
    >> Share

  5. VAN DER HEIDE A, Helmich RC
    Reply to "Reconsidering Central and Peripheral Contributions to Propranolol's Antitremor Effects in Parkinson's Disease".
    Ann Neurol. 2025 Aug 11. doi: 10.1002/ana.70016.
    >> Share

  6. VAN DUIJVENBODEN S, Ramirez J, Scheurink J, Darweesh SKL, et al
    Heart Rate Profiles During Exercise and Incident Parkinson's Disease.
    Ann Neurol. 2025 Aug 2. doi: 10.1002/ana.70010.
    >> Share

    July 2025
  7. LIU M
    From Topography to Therapy: Rethinking Cognitive Monitoring in GBA1-Linked Parkinson's Disease.
    Ann Neurol. 2025 Jul 29. doi: 10.1002/ana.70007.
    >> Share

  8. COLLOMB-CLERC A, Yeche M, Demain A, Van Hamme A, et al
    Subthalamic Electrophysiological Mapping of Gait Initiation Dynamics and Freezing in Parkinson's Disease.
    Ann Neurol. 2025 Jul 25. doi: 10.1002/ana.70003.
    >> Share

  9. ZHU S, Hong R, Wu Z, Bao Y, et al
    Sternocleidomastoid Muscle Overactivity: A Potentially Critical Contributor to Postural Abnormalities in Parkinson's Disease.
    Ann Neurol. 2025 Jul 16. doi: 10.1002/ana.27310.
    >> Share

    June 2025
  10. KANNARKAT GT, Zack R, Skrinak RT, Morley JF, et al
    Blood alpha-Synuclein Separates Parkinson's Disease from Dementia with Lewy Bodies.
    Ann Neurol. 2025 Jun 16. doi: 10.1002/ana.27288.
    >> Share

  11. MAFTEI D, Di Certo MG, Maurizi R, Veltri F, et al
    alpha-Synuclein-Related Mitochondria-Nrf2 Dysfunction in Parkinson's Disease Olfactory Mucosa.
    Ann Neurol. 2025 Jun 12. doi: 10.1002/ana.27292.
    >> Share

    April 2025
  12. MULLER L, Ozduzenciler P, Schedlich-Teufer C, Seger A, et al
    Elevated alpha-Synuclein Aggregate Levels in the Urine of Patients with Isolated REM Sleep Behavior Disorder and Parkinson's Disease.
    Ann Neurol. 2025 Apr 26. doi: 10.1002/ana.27250.
    >> Share

  13. SLINGERLAND S, van der Zee S, Carli G, Slomp AC, et al
    Cholinergic Degeneration and Cognitive Function in Early GBA1-Related Parkinson's Disease.
    Ann Neurol. 2025 Apr 16. doi: 10.1002/ana.27248.
    >> Share

  14. SUN QY, Tang FL, Zhou Y, Pan HX, et al
    Biallelic Variants in EPG5 Gene Are Associated with Parkinson's Disease.
    Ann Neurol. 2025 Apr 7. doi: 10.1002/ana.27242.
    >> Share

  15. BROWN EG, Chahine LM, Siderowf A, Gochanour C, et al
    Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease.
    Ann Neurol. 2025;97:730-740.
    >> Share

    March 2025
  16. DZIALAS V, Bischof GN, Mollenhoff K, Drzezga A, et al
    Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease.
    Ann Neurol. 2025 Mar 27. doi: 10.1002/ana.27223.
    >> Share

  17. SOMERVILLE EN, James A, Beetz C, Schwieger R, et al
    Plasma Glucosylceramide Levels Are Regulated by ATP10D and Are Not Involved in Parkinson's Disease Pathogenesis.
    Ann Neurol. 2025 Mar 1. doi: 10.1002/ana.27219.
    >> Share

    February 2025
  18. DAGAY A, Katzav S, Wasserman D, Gnoni V, et al
    Cyclic Alternating Pattern Dynamics in Individuals at Risk for Developing Parkinson's Disease.
    Ann Neurol. 2025 Feb 21. doi: 10.1002/ana.27217.
    >> Share

  19. BACKMAN EA, Gardberg M, Luntamo L, Peurla M, et al
    Nigral Neuroinflammation and Dopaminergic Neurons in Parkinson's Disease and Atypical Parkinsonisms.
    Ann Neurol. 2025 Feb 7. doi: 10.1002/ana.27202.
    >> Share

    January 2025
  20. DI BIASE L, Pecoraro PM, Di Lazzaro V
    Validating the Accuracy of Parkinson's Disease Clinical Diagnosis: A UK Brain Bank Case-Control Study.
    Ann Neurol. 2025 Jan 27. doi: 10.1002/ana.27190.
    >> Share

  21. SNAPYAN M, Desmeules F, Munro J, Berard M, et al
    Adult Neurogenesis in the Subventricular Zone of Patients with Huntington's and Parkinson's Diseases and following Long-Term Treatment with Deep Brain Stimulation.
    Ann Neurol. 2025 Jan 19. doi: 10.1002/ana.27181.
    >> Share

  22. LI J, Chen D, Tang Y, Chen Z, et al
    Synaptic Density Reductions in MSA: A Potential Biomarker Identified Through [(18)F]SynVesT-1 PET Imaging.
    Ann Neurol. 2025 Jan 19. doi: 10.1002/ana.27179.
    >> Share

    December 2024
  23. VAN DER HEIDE A, Wessel M, Papadopetraki D, Geurts DEM, et al
    Propranolol Reduces Parkinson's Tremor and Inhibits Tremor-Related Activity in the Motor Cortex: A Placebo-Controlled Crossover Trial.
    Ann Neurol. 2024 Dec 21. doi: 10.1002/ana.27159.
    >> Share

  24. FLORES-TORRES MH, Hughes KC, Cortese M, Hung AY, et al
    Identifying Individuals in the Prodromal Phase of Parkinson's Disease: A Prospective Cohort Study.
    Ann Neurol. 2024 Dec 19. doi: 10.1002/ana.27166.
    >> Share

  25. DAIDA K, Yoshino H, Malik L, Baker B, et al
    The Utility of Long-Read Sequencing in Diagnosing Early Onset Parkinson's Disease.
    Ann Neurol. 2024 Dec 19. doi: 10.1002/ana.27155.
    >> Share

    October 2024
  26. CHERIF S, Tempier N, Yeche M, Temiz G, et al
    Directional Subthalamic Deep Brain Stimulation Better Improves Gait and Balance Disorders in Parkinson's Disease Patients: A Randomized Controlled Study.
    Ann Neurol. 2024 Oct 30. doi: 10.1002/ana.27099.
    >> Share

    September 2024
  27. BRUMBERG J, Blazhenets G, Buhler S, Fostitsch J, et al
    Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases.
    Ann Neurol. 2024;96:539-550.
    >> Share

  28. CAMERUCCI E, Mullan AF, Turcano P, Stang CD, et al
    A Population-Based Approach to the Argument on Brain-First and Body-First Pathogenesis of Lewy Body Disease.
    Ann Neurol. 2024;96:551-559.
    >> Share

    August 2024
  29. PUIG-DAVI A, Martinez-Horta S, Perez-Carasol L, Horta-Barba A, et al
    Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4-Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers.
    Ann Neurol. 2024 Aug 5. doi: 10.1002/ana.27035.
    >> Share

    May 2024
  30. ARENA G, Landoulsi Z, Grossmann D, Payne T, et al
    Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease.
    Ann Neurol. 2024 May 20. doi: 10.1002/ana.26949.
    >> Share

  31. SAARINEN EK, Kuusimaki T, Lindholm K, Niemi K, et al
    Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease.
    Ann Neurol. 2024 May 20. doi: 10.1002/ana.26957.
    >> Share

  32. ZAMPOGNA A, Suppa A, Bove F, Cavallieri F, et al
    Disentangling Bradykinesia and Rigidity in Parkinson Disease: Evidence from Short- and Long-Term Subthalamic Nucleus Deep Brain Stimulation.
    Ann Neurol. 2024 May 9. doi: 10.1002/ana.26961.
    >> Share

  33. PRASUHN J, Schiefen T, Guber T, Henkel J, et al
    Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo.
    Ann Neurol. 2024;95:849-857.
    >> Share

    April 2024
  34. GONZALEZ-LATAPI P, Bustos B, Dong S, Lubbe S, et al
    Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease.
    Ann Neurol. 2024 Apr 2. doi: 10.1002/ana.26923.
    >> Share

  35. POST E, Hall DA, Bloem BR
    Reply to "An Apple a Day Will Not Keep the (Parkinson's Disease) Doctor at Bay!".
    Ann Neurol. 2024 Apr 1. doi: 10.1002/ana.26937.
    >> Share

  36. KHANI M, Cerquera-Cleves C, Kekenadze M, Wild Crea P, et al
    Towards a Global View of Parkinson's Disease Genetics.
    Ann Neurol. 2024 Apr 1. doi: 10.1002/ana.26905.
    >> Share

  37. SAKOWSKI SA, Koubek EJ, Chen KS, Goutman SA, et al
    Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions.
    Ann Neurol. 2024;95:635-652.
    >> Share

    March 2024
  38. BOOGERS A, Fasano A, Lang A
    An Apple a Day Will Not Keep the (Parkinson Disease) Doctor at Bay!
    Ann Neurol. 2024 Mar 30. doi: 10.1002/ana.26936.
    >> Share

  39. KLUGE A, Borsche M, Streubel-Gallasch L, Gul T, et al
    alpha-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification Assay.
    Ann Neurol. 2024 Mar 28. doi: 10.1002/ana.26917.
    >> Share

  40. DEL BENE VA, Martin RC, Brinkerhoff SA, Olson JW, et al
    Differential Cognitive Effects of Unilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.
    Ann Neurol. 2024 Mar 19. doi: 10.1002/ana.26903.
    >> Share

  41. ARNALDI D, Mattioli P, Raffa S, Pardini M, et al
    Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.
    Ann Neurol. 2024 Mar 11. doi: 10.1002/ana.26902.
    >> Share

    December 2023
  42. WIESMAN AI, da Silva Castanheira J, Fon EA, Baillet S, et al
    Alterations of cortical structure and neurophysiology in Parkinson's disease are aligned with neurochemical systems.
    Ann Neurol. 2023 Dec 26. doi: 10.1002/ana.26871.
    >> Share

  43. REYNOSO A, Torricelli R, Jacobs BM, Shi J, et al
    Gene-environment interactions for Parkinson's disease.
    Ann Neurol. 2023 Dec 19. doi: 10.1002/ana.26852.
    >> Share

    November 2023
  44. ZHOU L, Li SX, Chau SW, Huang B, et al
    Altered impulsivity across drug-naive parkinsonism, isolated REM sleep behavior disorder, and their high-risk relatives.
    Ann Neurol. 2023 Nov 23. doi: 10.1002/ana.26836.
    >> Share

  45. CHUN MY, Chung SJ, Kim SH, Park CW, et al
    Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson's Disease: An Early-Phase (18) F-FP-CIT PET Study.
    Ann Neurol. 2023 Nov 14. doi: 10.1002/ana.26827.
    >> Share

    August 2023
  46. MOHAMMADZADEH N, Tung GA, Prakash P, Alhusaini S, et al
    Parkinsonism: A Rare Complication of Cerebral Toxoplasmosis.
    Ann Neurol. 2023 Aug 30. doi: 10.1002/ana.26777.
    >> Share

  47. KANG X, Ploner A, Roelstraete B, Ludvigsson JF, et al
    Risk of Parkinson's disease in celiac disease: A Swedish population-based study.
    Ann Neurol. 2023 Aug 26. doi: 10.1002/ana.26780.
    >> Share

    June 2023
  48. HE P, Shi L, Li Y, Duan Q, et al
    The Association of the Glymphatic Function with Parkinson's Disease Symptoms: Neuroimaging Evidence from Longitudinal and Cross-sectional Studies.
    Ann Neurol. 2023 Jun 28. doi: 10.1002/ana.26729.
    >> Share

  49. NIETHAMMER M, Tang CC, Jamora RDG, Vo A, et al
    A network imaging biomarker of X-linked dystonia-parkinsonism.
    Ann Neurol. 2023 Jun 27. doi: 10.1002/ana.26732.
    >> Share

  50. PALACIOS N, Wilkinson J, Bjornevik K, Schwarzschild MA, et al
    Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes.
    Ann Neurol. 2023 Jun 14. doi: 10.1002/ana.26719.
    >> Share

    May 2023
  51. HACKER ML, Rajamani N, Neudorfer C, Hollunder B, et al
    Connectivity Profile for Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease.
    Ann Neurol. 2023 May 13. doi: 10.1002/ana.26674.
    >> Share

  52. WILKINS KB, Kehnemouyi YM, Petrucci MN, Anderson RW, et al
    Bradykinesia and Its Progression Are Related to Interhemispheric Beta Coherence.
    Ann Neurol. 2023;93:1029-1039.
    >> Share

    April 2023
  53. NEDELEC T, Couvy-Duchesne B, Darves-Bornoz A, Couronne R, et al
    A comparison between early presentation of dementia with Lewy Bodies, Alzheimer's disease and Parkinson's disease: evidence from routine primary care and UK Biobank data.
    Ann Neurol. 2023 Apr 25. doi: 10.1002/ana.26670.
    >> Share

    March 2023
  54. LIU B, Svenningsson P, Ludvigsson JF, Lundholm C, et al
    beta2-adrenoreceptor agonists, montelukast, and Parkinson's disease risk.
    Ann Neurol. 2023 Mar 10. doi: 10.1002/ana.26638.
    >> Share

  55. LANORE A, Casse F, Tesson C, Courtin T, et al
    Differences in survival across monogenic forms of Parkinson's disease.
    Ann Neurol. 2023 Mar 10. doi: 10.1002/ana.26636.
    >> Share

  56. TROPEA TF, Albuja I, Cousins KAQ, Irwin DJ, et al
    Concomitant Alzheimer's Disease Pathology in Parkinson's Disease Dementia.
    Ann Neurol. 2023 Mar 9. doi: 10.1002/ana.26635.
    >> Share

  57. YOUNCE JR, Martin WRW, Perlmutter JS
    Reply to "Concomitant Alzheimer's Disease Pathology in Parkinson's Disease Dementia".
    Ann Neurol. 2023 Mar 9. doi: 10.1002/ana.26630.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016